Searched for
DCGI NOTICE
Regulator bans 35 combination drugs over safety issuesIndia's drug regulator has banned the manufacture and sale of 35 fixed dose combinations (FDCs), citing concerns over patient safety and po...- DCGI suspends nod to Entod's new eye drops over unapproved 'claims'India's drug regulator has suspended Entod Pharmaceuticals' permission to manufacture and sell PresVu Eye Drops. The company did not obtain...
- Regulator moves to check import of fake cosmeticsThe Drugs Controller General of India (DCGI) has asked importers of cosmetics to provide information on consignments, bills, quantity impor...
- New initiative by Drug Controller General of India to boost ease of doing businessThe Drug Controller General of India (DCGI) plans to hold walk-in meetings with stakeholders to improve the ease of doing business in India...
- PharmEasy mails health minister for quick draft rules notificationPharmEasy parent API Holdings wrote to health minister Mansukh Mandaviya asking for an urgent meeting with the delegation of online pharmac...
- All medicines to be sold under supervision of pharmacist, mandates DCGINewly-appointed DCGI Rajeev Singh Raghuvanshi has asked the state drug controllers to ensure that pharmacists should be physically present ...
- Amazon, Flipkart among 20 e-tailors given notices for selling drugs without licenceThe notice stated that the DCGI had forwarded the order to all state and Union Territories in May and November 2019 and again on February 3...
- DCGI sends notices to e-pharmacies for selling drugs without licenceIn the notices, issued on Wednesday, the regulator said the online platforms were doing the business in contravention of the Drugs and Cosm...
- DGCI directs Serum Institute to suspend any new recruitment in phase 2, 3 COVID-19 vaccine clinical trialsOn 9 September ANI first reported that DCGI issued a show-cause notice to Serum Institute for not pausing the ongoing clinical trial of the...
- AstraZeneca trials only after review by UK’s Drug and Safety Monitoring Board: Serum InstituteThe decision to put the trials on hold was taken by the members of the DSMB after they were informed about the serious adverse events repor...
- Glenmark defends price of its COVID-19 drug favipiravir version after DCGI sends notice“Compared to other therapies approved for emergency use in COVID-19, FabiFlu is much more economical and an effective treatment option,” th...
- Drug regulator issues notice to Amazon, Flipkart for alleged sale of spurious cosmeticsThe law provides for penal actions ranging from monetary fine to imprisonment for sale of such "unapproved" products.
- Roche begins probe into Avastin use for eye ailmentsRoche has initiated an internal investigation following reports the it had been used in certain eye ailments and damaged the vision of 15 p...
- DCGI asks Novartis to explain 'violations' in papers on drug manufactureDCGI has sought an explanation for the "violation" in 10 days, apart from asking for detailed documentation for all imported products.
- Unwanted 72, i-pill makers get notice over adsThe Drug Controller General Of India (DCGI) has issued showcause notices to Piramal Healthcare, Mankind Pharma and Morepen Laboratories for...
- DCGI asks GSK to withdraw promotional advertisementNational health regulator Drug Controller General of India has asked GlaxoSmithKline to withdraw promotional advertisement for cervical can...
- FDA-approved inspectors plan short-notice audit of trialsUnder the scheme, a team of drug inspectors will walk into clinical trial centres at short notice and audit the internal processes and the ...
- Drugs with composition change need fresh approvalCompanies, which replace price-controlled ingredients in a drug with those outside control, will not be allowed to sell those drugs under t...
- DCGI likely to invoke special provisions to ban 294 drugsFaced with resistance from drug makers and legal reversals, the Drug Controller General of India (DCGI) will use all means within his comma...
- Pharma cos see legal way out of combo banThe Madras High Court has stayed the Drug Controller General of India (DCGI) and Puducherry’s drug regulator’s order to withdraw 294 fixed ...
Load More
